Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Serine/Glycine Restriction and PD-L1 Lactylation
2026-08-25
The reference study shows that a serine/glycine-free diet can restrain colorectal cancer growth while increasing cytotoxic T-cell activity, but may also promote immune escape through PD-L1 lactylation. Its combination of mechanistic tumor studies and an early clinical feasibility study provides a useful framework for evaluating nutrient-restricted diets alongside immune checkpoint therapy.
-
Direct Mouse Genotyping Kit Plus for Macrophage Studies
2026-08-25
Connect rapid, purification-free mouse genotyping with lineage-tracing, transgene, and knockout workflows in immuno-oncology research. This practical guide shows how to use direct lysates, high-fidelity PCR, and dye-enabled electrophoresis while avoiding common inhibitors and genotype miscalls.
-
Estradiol: From Receptor Bias to Organ-Level Assays
2026-08-24
Estradiol and 17 beta-estradiol are powerful tools for connecting estrogen receptor signaling with tissue-level biology. This article presents an assay-interpretation framework that links receptor context, autophagy, and organ protection without confusing correlation with mechanism.
-
Meropenem Trihydrate: From Mechanism to Translation
2026-08-24
Meropenem trihydrate can serve as more than a broad-spectrum antibacterial control. By pairing its penicillin-binding protein mechanism with LC-MS/MS metabolomics, researchers can connect resistance phenotypes to measurable metabolic states and build more translational infection models.
-
Standardized Whole-Blood Immunometabolism Assay
2026-08-23
Zhao and colleagues present a standardized whole-blood stimulation protocol for testing how metabolic interventions shape human immune responses. By combining defined immune stimuli, pathway-directed inhibitors, and cytokine quantification, the workflow supports reproducible immunometabolism research while preserving the cellular complexity of whole blood.
-
EGTA for Calcium Signaling Assay Design
2026-08-22
EGTA, or egtazic acid, offers a practical way to test whether extracellular calcium drives neuronal injury, synaptic excitation, inflammation, or apoptosis. This workflow-focused guide connects selective calcium chelation with electrophysiology, cell viability assays, and troubleshooting strategies for reproducible experiments.
-
Pifithrin-α: p53 Inhibitor Evidence & Workflow
2026-08-22
Pifithrin-α is a p53 inhibitor used to test p53-dependent apoptosis, growth arrest, and ferroptosis mechanisms. Evidence from irradiated cellular models and a deltamethrin neurotoxicity study supports mechanistic use, but does not establish clinical cancer therapy side effect mitigation.
-
Fraxinellone Activates PINK1/Parkin Mitophagy in IBD
2026-08-21
The reference study identifies fraxinellone as a potential modulator of mitochondrial quality control in inflammatory bowel disease. Using DSS and LPS injury models, molecular docking, CETSA, and PINK1 knockdown, the authors link fraxinellone protection to PINK1/Parkin-dependent mitophagy rather than to nonspecific anti-inflammatory activity alone.
-
BCECF for Extracellular pH Assays
2026-08-20
BCECF provides a ratiometric way to connect extracellular acidity with ion transport, macrophage function, and disease-model biology. This practical guide explains how to calibrate the probe, integrate it with efferocytosis workflows, and avoid confusing extracellular pH changes with intracellular readouts.
-
DCPS and m7G Signaling in Diabetic Foot Ulcers
2026-08-20
A 2025 study identified the decapping scavenger enzyme DCPS as an m7G-related biomarker associated with diabetic foot ulcer biology. Integrating transcriptomic analysis with keratinocyte perturbation experiments, the authors linked reduced DCPS to impaired cell-cycle progression, proliferation, migration, and increased apoptosis, providing a testable framework for epithelial wound-healing research.
-
TUDCA Workflows for ER Stress and NAFLD Research
2026-08-19
Tauroursodeoxycholic Acid gives researchers a practical chemical-chaperone approach for separating ER stress, mitochondrial injury, apoptosis, and autophagy defects. This workflow connects TUDCA treatment with the Galectin-1–FIP200 mechanism reported in hepatic steatosis, enabling more discriminating metabolic disease assays.
-
In Vitro Drug Response: Growth Inhibition vs Cell Death
2026-08-19
Hannah R. Schwartz’s dissertation, In Vitro Methods to Better Evaluate Drug Responses in Cancer, distinguishes relative viability from fractional viability as separate dimensions of anticancer response. Its findings indicate that drug-induced proliferation arrest and cell death frequently occur together but differ in magnitude and timing, supporting paired, time-aware assay designs.
-
Tofacitinib RA Macrophage Workflows
2026-08-18
Tofacitinib (CP-690550) is a practical probe for dissecting JAK/STAT-dependent inflammation in GM-CSF-reprogrammed macrophages. This workflow guide connects cytokine signaling blockade with mitochondrial and metabolic readouts, while providing dose-design, assay-integration, and troubleshooting strategies.
-
RNA Pol II Loss Activates Apoptosis Beyond Transcription
2026-08-18
Harper et al. show that RNA Pol II inhibition kills cells through an active apoptotic response triggered by depletion of hypophosphorylated RNA Pol IIA, rather than through transcriptional collapse alone. Their functional-genomics framework identifies the Pol II degradation-dependent apoptotic response (PDAR) and explains why several mechanistically diverse drugs can converge on this pathway.
-
Hematoxylin and Eosin Staining Kit Guide
2026-08-17
The Hematoxylin and Eosin Staining Kit supports routine visualization of nuclei, cytoplasm, and extracellular matrix in paraffin-embedded tissue, frozen sections, and cytological preparations. It is intended for research workflows rather than diagnostic or medical use, and laboratories should validate fixation, staining times, and ancillary reagents for each specimen type.